Antibody‐Directed Enzyme Prodrug Therapy: A Promising Approach for a Selective Treatment of Cancer Based on Prodrugs and Monoclonal Antibodies
Authors:
- 17 August 2009
- journal article
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 74 (3) , 205-211
Abstract
The antibody‐directed enzyme prodrug therapy allows a selective liberation of cytotoxic agents from non‐toxic prodrugs in cancerous tissue by targeted antibody–enzyme conjugates. We have developed a series of novel glycosidic prodrugs based on the natural antibiotic CC‐1065 and the duocarmycins, which are up to 4800 times less toxic than the drugs liberated from these prodrugs in the presence of the activating enzyme (e.g., β‐d‐galactosidase). Furthermore, the drugs show very high cytotoxicities with IC50 values of as low as 4.5 pm. In this report, we summarize our recent results on the development and biological evaluation of these novel third‐generation prodrugs with higher water solubility, higher difference in cytotoxicity between the prodrugs and the corresponding drugs and improved cytotoxicity of the drugs as compared with previous compounds.Keywords
This publication has 37 references indexed in Scilit:
- Synthesis and Biological Studies of Different Duocarmycin Based Glycosidic Prodrugs for Their Use in the Antibody-Directed Enzyme Prodrug TherapyJournal of Medicinal Chemistry, 2008
- Asymmetric Synthesis and Biological Evaluation of Glycosidic Prodrugs for a Selective Cancer TherapyChemMedChem, 2008
- Synthesis and Biological Evaluation of a Novel Pentagastrin- Toxin Conjugate Designed for a Targeted Prodrug Monotherapy of CancerInternational Journal of Molecular Sciences, 2008
- Prodrugs: design and clinical applicationsNature Reviews Drug Discovery, 2008
- Selective Treatment of Cancer: Synthesis, Biological Evaluation and Structural Elucidation of Novel Analogues of the Antibiotic CC‐1065 and the DuocarmycinsChemistry – A European Journal, 2007
- Selective delivery of therapeutic agents for the diagnosis and treatment of cancerExpert Opinion on Biological Therapy, 2005
- Targeted prodrug design to optimize drug deliveryAAPS PharmSci, 2000
- New Course in the Search for Antitumor Agents: The Use of pH‐Dependent Sources of Reactive RadicalsAngewandte Chemie International Edition, 1996
- Glycosidation, 15. — Anticancer agents, 11. Development of selective anticancer agents synthesis of acetal‐β‐glucosides from cytotoxic alcoholsEuropean Journal of Organic Chemistry, 1990
- Stereoselective Synthesis of β‐Glucosides with l, l′‐Diacetal StructureAngewandte Chemie International Edition, 1981